30% of collaborative PhD studentships are co-funded by the Biotechnology and Biological Sciences Research Council (BBSRC), while the Engineering and Physical Sciences Research Council (EPSRC) funds 25%. This is a decrease from 2015, where the BBSRC and EPSRC accounted for co-funding of 35% and 27% of collaborative PhD studentships respectively. However, the 2017 proportion is similar to that seen in 2013 and 2011 for the BBSRC, while the EPSRC proportion is greater than in those years.
There is an increase in the number of studentships funded in part by the university partner, from 35 in 2015 to 60 in 2017, while companies are also funding 93 studentships without any other co-funder, a similar state to the 85 fully-funded PhDs in 2015. After several years of the MRC co-funding a decreasing number of PhD studentships, there is a slight increase in 2017, from 19 in 2015 to 26. It will be interesting to see whether the pattern of funding collaborative PhDs with the pharmaceutical industry by the UK research councils will be affected by the launch of UK Research and Innovation in 2018.